Aug 2026· Bioinformatics· Vol 42· 0 citations· 21 references
Medicine
Abstract
Abstract Motivation To enable real-world protein-ligand affinity prediction, not only out-of-distribution generalization but also robustness to variable structural availability and quality should be considered in model design. Results We present AlignNet, a hierarchical representation alignment framework that mitigates intra- and inter-molecular heterogeneity to learn robust protein-ligand embeddings for generalizable affinity prediction, even from sequence-level inputs. Its intra-molecular module projects unimodal and multimodal features into a unified space, aligning augmented multimodal views for feature fusion and unimodal with multimodal embeddings to distill multimodal priors for structure-agnostic inference. Its inter-molecular module aligns protein and ligand embeddings for cross-molecular integration. Extensive experiments show that AlignNet (i) achieves highly competitive performance, with up to a 20.4% gain in SCC on the challenging LBA 30% split under sequence-only settings, suggesting improved out-of-distribution generalization; and (ii) learns well-separated affinity-related clusters, supporting reliable structure-independent prediction. Availability and implementation AlignNet is available at https://github.com/altriavin/AlignNet.
By combining protein language model embeddings with topology-adaptive geometric reasoning, DiConSite offers a reusable framework for residue-level protein interaction analysis and achieves consistently strong and often best-performing results, while improving robustness to structural uncertainty and cross-modal variation.
Shouzhi Chen, Zhenchao Tang, Linlin You et al.· IEEE Transactions on Pattern...· 1 citation
Protein-ligand binding affinity (PLA) prediction aims to guide rational drug design by estimating the strength of interaction. The effectiveness of the representation learning of protein and ligand is key to successful PLA prediction. To this end, attention mechanism, as a powerful architectural paradigm, has been introduced and gradually emerged as the prevailing approach. However, intuitively, the classical attention paradigm based on similarity does not fit the biological mechanisms relevant for binding. Worse still, the cooperative and antagonistic effects among multiple atoms are deliberately disregarded in the classical formulation of attention mechanisms. Consequently, the rigid transplantation of classical architectures substantially undermines the PLA prediction performance. To address these challenges, we employ a hierarchical statistical attention model (HISA). Specifically, HISA employs a statistical attention mechanism (SAM) based on non-similarity computation to fit the biological prior and perceive the relationship of multiple atoms. In addition, we optimize HISA by employing clustering, enabling hierarchical representations of biomolecules. Extensive experiments demonstrate that HISA achieves state-of-the-art performance on multiple PLA benchmarks while simultaneously exhibiting generalizability and interpretability.
Changming Yao, Shunfanyi Li, Shanghui Deng et al.· IEEE transactions on computa...· 0 citations
The resulting model, HydrAffinity, is an interaction-free, dynamic sparse model that uses pre-trained encoders and MoE for parameter-efficient learning and outperforms all interaction-free methods and matches state-of-the-art interaction-based methods on CASF-2016.
MIRAGE provides an interpretable and robust framework for structure-aware prediction, with potential applications in protein engineering and drug design, and explicitly modeling multi-level interactions is important for accurately capturing the determinants of binding affinity.
This work designs a biological prior-guided feature fusion framework that integrates pseudo-structural epitope knowledge and CDR-specific attention mechanisms via a mixture-of-experts architecture to effectively capture complex binding landscapes in antibody screening and drug residence time analysis.
G. Luo, Junkai Wang, Sizhe Zhang et al.· Bioinformatics· 0 citations